New Delhi, 27th September 2024: In an exciting leap forward for orthopaedic care, Auxein Medical has made its debut at IASCON 2024, where the organisation showcased its groundbreaking research on bioabsorbable screws and engage with the arthroscopy community. Pioneering the Future of Orthopaedic Implants with Bioabsorbable Technology Auxein showcased its dedication to innovation in healthcare solutions.
Mr. Gaurav Luthra, Vice President Global Manufacturing, Regulatory Head, Auxein Medical, said “Auxein Medical’s commitment to enhancing patient outcomes begins with substantial investments in state-of-the-art technology. The company has imported advanced machinery from Germany to establish a robust manufacturing process for bioabsorbable screws. Additionally, Auxein has acquired land expanding its manufacturing unit from 3,150 square meters to 4,050 square meters. This expansion will allow for an increased range of orthopaedic and arthroscopy products, including the groundbreaking bioabsorbable implants. Auxein Medical is dedicated to innovation, reinvesting 12% of its total revenue into research and development each year. This commitment underscores the company’s focus on creating advanced solutions that address the evolving needs of patients and healthcare providers.”
Mr. Manoharan Govinda Pillai, Director of Quality, Auxein Medical and Ex- Scientist from ISRO, said, “Bioabsorbable implants are set to revolutionize orthopaedic surgery. Made from biocompatible materials, these innovative implants dissolve gradually in the body, providing temporary support that aids in natural healing and tissue regeneration. Unlike traditional metallic implants, bioabsorbable options minimize complications, reducing the need for invasive removal surgeries.”
The orthopaedic implant market in India is on the brink of transformation, driven by technological advancements and an increasing focus on sustainable healthcare practices. By 2031, the market is projected to surpass $56.3 billion, reflecting a compound annual growth rate (CAGR) of 5.0% from 2022. The rise of bioabsorbable implants aligns perfectly with this trend, highlighting a growing demand for solutions that prioritize patient care and environmental sustainability. The bioabsorbable implant market is expected to grow from $664.8 million in 2024 to $836.5 million by 2034, driven by the increasing need for solutions that address age-related health concerns.
Key Benefits of Bioabsorbable Implants
-
Gradual Dissolution: Eliminates the need for invasive removal surgeries.
-
Lower Complication Risks: Reduces the risk of infection and metal sensitivity.
-
Supports Natural Healing: Facilitates bone growth and integration.
-
Immediate Stabilization: Enhances patient comfort during recovery.
The introduction of bioabsorbable implants marks a significant milestone in orthopaedic surgery, emphasizing Auxein Medical’s dedication to patient care and sustainability. By prioritizing indigenous manufacturing and continuous research, Auxein is set to transform the orthopaedic implant market in India and beyond, offering innovative solutions that not only improve patient outcomes but also reduce environmental impact.